SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alchemy Pay

Alchemy Pay (ACH) is trending amid active discussions surrounding its strategic partnerships, including a recent integration with Ripple's RLUSD stablecoin to enhance global fiat on-ramps. The community is also focused on ACH's expanding regulatory footprint with new US Money Transmitter Licenses and the anticipated launch of its stablecoin-centric Alchemy Chain, driving optimism for its future in crypto payments.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is drawing significant attention following its J.P. Morgan Healthcare Conference presentation and compelling clinical data, notably an 81% disease control rate in advanced pancreatic cancer. The community is buzzing with anticipation for imminent PMDA approval in Japan and potential institutional investment, like Cathie Wood's ARK fund, viewing DRTS as an undervalued leader in groundbreaking targeted alpha therapy for various solid tumors.

Hut 8 Corp. operates as a Bitcoin miner that focuses on mining. It provides digital asset mining, hosting, and managed infrastructure operation services. The company was founded on January 27, 2023 and is headquartered in Miami, FL.

Hut 8 Corp

Hut 8 is trending due to its recently announced AI infrastructure partnership with Anthropic and Fluidstack, which includes a significant 15-year data center lease at its River Bend campus, notably backed by Google. The community is actively discussing this strategic pivot, with many viewing Hut 8 as a leading AI play and anticipating substantial growth, while others express concerns about its valuation and continued exposure to crypto market dynamics.

Chiliz is a fintech platform for the sports industry to allow global fans to get closer to their favorite sports teams and clubs.

Chiliz

Chiliz (CHZ) is trending amid recent regulatory clarity from MiCA compliance in Europe and strategic expansion into new markets, including K-Pop and integrations with South Korea's Naver Pay. The community is actively discussing its potential for significant growth, fueled by these foundational developments and strong anticipation around the upcoming European Football Championship.

BlackPearl.Chain is pushing decentralization into the future with a third-generation public blockchain. It’s network achieves blazing transaction speeds (Millions TPS) using Sharding and a VRF lightning-fast consensus mechanism built in-house. Finality is achieved in under three seconds with revolutionary P2P, Its speed and security make it the perfect platform for applications like digital asset trading, social media messaging, payment processing, supply chain tracking, and other high-scale use cases.

BlackPearl

The BPLC crypto community is highly optimistic about its long-term potential, with many envisioning it as a future "game changer" in commerce. Enthusiastic investors are comparing it to established digital assets like XRP, eagerly anticipating mainstream exchange adoption and significant market cap expansion.

Booking Holdings, Inc. engages in the provision of online travel and related solutions. The firm offers services through the following brands: Booking.com, Priceline, Agoda, KAYAK, and OpenTable. It provides accommodation reservations including hotels, hostels, apartments, vacation rentals, and other properties. The company was founded by Jay Scott Walker on July 18, 1997, and is headquartered in Norwalk, CT.

Booking Holdings Inc

Booking Holdings is trending following its recent strong earnings report and optimistic outlook, which showcased robust global travel demand and strategic initiatives. However, market participants are actively weighing the potential impact of Google's expanding AI-powered travel tools and ongoing significant European legal challenges against the company's future growth, while calls for a stock split remain a popular talking point.

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD is trending as natural gas prices decline, primarily driven by consistently warmer U.S. weather forecasts that reduce heating demand and maintain ample storage levels. The trading community is actively capitalizing on this bearish natural gas outlook by going long KOLD, with many highlighting its current profitability. This trend is further supported by persistently high natural gas production, reinforcing an oversupply narrative.

Astera Labs, Inc. is a global semiconductor company, which engages in the provision of hardware and software solutions for AI and cloud infrastructure applications to solve data, memory, and networking bottlenecks. It operates through the following geographical segments: Taiwan, China, United States, and Other. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

Astera Labs (ALAB) is experiencing significant market volatility and community debate, stemming from recent AI infrastructure news involving a major hyperscaler that sparked sharp price movements. Investors are actively discussing whether the initial market reaction was an overcorrection, with many highlighting ALAB's fundamental strength in high-speed AI connectivity and its long-term potential in the burgeoning semiconductor sector.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending following activist investor Shah Capital's increased stake and mounting pressure for strategic changes, including a potential proxy fight or buyout. Community discussion centers on discontent with current management's perceived lack of execution and communication after the CEO's remarks at a major industry conference, intensifying calls for tangible action like a share buyback to unlock value from its core technology amidst high short interest.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is trending amid a significant sell-off, fueled by its recent acquisition of Armis for $7.75 billion and widespread fears about AI disrupting the broader enterprise software sector. The community is sharply divided, with many seeing the stock as deeply oversold and a strong long-term play due to solid fundamentals, while others question its valuation and the impact of AI on traditional SaaS.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mind Medicine (MindMed) (NASDAQ:MNMD) Sets New 52-Week High - Still a Buy?

Mind Medicine (MindMed) (NASDAQ:MNMD) Hits New 52-Week High - Time to Buy...

Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 3.8% on Insider Selling

Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Down 3.8% After Insider Selling...

Mind Medicine (MindMed) (NASDAQ:MNMD) Insider Sells $148,279.40 in Stock

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) insider Mark Sullivan sold 11,276 shares of the firm's stock in a transaction dated Friday, December 26th. The stock was sold at an...

Mind Medicine (MindMed) (NASDAQ:MNMD) Insider Daniel Karlin Sells 5,600 Shares

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) insider Daniel Karlin sold 5,600 shares of the firm's stock in a transaction on Friday, December 26th. The stock was sold at an average...

Mind Medicine (MindMed) (NASDAQ:MNMD) Insider Mark Sullivan Sells 11,276 Shares

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) insider Mark Sullivan sold 11,276 shares of the company's stock in a transaction dated Friday, December 26th. The shares were sold at an...

Mind Medicine (MindMed) (NASDAQ:MNMD) CEO Sells $339,151.65 in Stock

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) CEO Robert Barrow sold 25,791 shares of the business's stock in a transaction dated Friday, December 26th. The shares were sold at an...

Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Up 3.1% - Should You Buy?

Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Up 3.1% - What's Next...

MNMD Stock Up More Than 100% in 6 Months: What's in Store for 2026?

MNMD has surged 101% in six months with MM120 advancing in phase III for GAD and MDD. Pivotal readouts are slated for 2026.

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Consensus Rating of "Buy" from Analysts

Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) have been assigned an average rating of "Buy" from the twelve ratings firms that are currently covering the firm, MarketBeat...

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Rating of "Buy" from Analysts

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) has received a consensus rating of "Buy" from the twelve analysts that are presently covering the stock, MarketBeat.com reports. One...

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Current Price	$15.01
Prev Close	$15.38
Open	$15.49
Dividend Yield	0.00%
50-Day Moving Average	$12.69
Beta	1.79
Avg. Volume	1.92M
PE Ratio	-7.63

52-Week High	$15.88
52-Week Low	$4.70
Market Capitalization	$1.48B
EPS (Annual)	-$1.54
Price to Book	8.85
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

MNMD
Mind Medicine Inc - Ordinary Shares (Sub Voting)

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MNMD News

MNMDMind Medicine Inc - Ordinary Shares (Sub Voting)